158 related articles for article (PubMed ID: 36627407)
1. Pilot study of the prevalence of autoimmune disorders in Li-Fraumeni syndrome.
Obregón IH; de Andrade KC; Bremer RC; Khincha PP; Savage SA
Fam Cancer; 2023 Jul; 22(3):319-321. PubMed ID: 36627407
[No Abstract] [Full Text] [Related]
2. [TP53 germline mutation related Li-Fraumeni syndrome: report of a case].
Liu XL; Jin XF; Song YL; Li GQ; Lin DL; Xing XM
Zhonghua Bing Li Xue Za Zhi; 2022 May; 51(5):458-460. PubMed ID: 35511646
[TBL] [Abstract][Full Text] [Related]
3. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
[TBL] [Abstract][Full Text] [Related]
4. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV
J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database Analysis.
Kratz CP; Freycon C; Maxwell KN; Nichols KE; Schiffman JD; Evans DG; Achatz MI; Savage SA; Weitzel JN; Garber JE; Hainaut P; Malkin D
JAMA Oncol; 2021 Dec; 7(12):1800-1805. PubMed ID: 34709361
[TBL] [Abstract][Full Text] [Related]
6. The Li-Fraumeni syndrome: an inherited susceptibility to cancer.
Evans SC; Lozano G
Mol Med Today; 1997 Sep; 3(9):390-5. PubMed ID: 9302689
[TBL] [Abstract][Full Text] [Related]
7. Spectrum and Incidence of Skin Cancer among Individuals with Li-Fraumeni Syndrome.
Hatton JN; Sargen MR; Frone MN; de Andrade KC; Savage SA; Khincha PP
J Invest Dermatol; 2022 Sep; 142(9):2534-2537.e1. PubMed ID: 35183552
[No Abstract] [Full Text] [Related]
8. Sotos Syndrome with NSDI Gene Mutations and Li-Fraumeni Syndrome with TP53 Gene Mutations in a Patient with Multiple Gastric Signet-Ring Cell Carcinomas.
Li Y; Wang W; Sun W; Wu X; Zhao B; Dou X; Wang L; Chen M
Dig Dis Sci; 2024 Feb; 69(2):315-317. PubMed ID: 38147236
[No Abstract] [Full Text] [Related]
9. Germ line BAX alterations are infrequent in Li-Fraumeni syndrome.
Barlow JW; Mous M; Wiley JC; Varley JM; Lozano G; Strong LC; Malkin D
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1403-6. PubMed ID: 15298965
[TBL] [Abstract][Full Text] [Related]
10.
Fortuno C; Richardson M; Pesaran T; Yussuf A; Horton C; James PA; Spurdle AB
J Med Genet; 2023 Nov; 60(12):1215-1217. PubMed ID: 37536919
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.
Penkert J; Schmidt G; Hofmann W; Schubert S; Schieck M; Auber B; Ripperger T; Hackmann K; Sturm M; Prokisch H; Hille-Betz U; Mark D; Illig T; Schlegelberger B; Steinemann D
Breast Cancer Res; 2018 Aug; 20(1):87. PubMed ID: 30086788
[TBL] [Abstract][Full Text] [Related]
12. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
[TBL] [Abstract][Full Text] [Related]
13. Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.
Kamihara J; Rana HQ; Garber JE
Hum Mutat; 2014 Jun; 35(6):654-62. PubMed ID: 24706533
[TBL] [Abstract][Full Text] [Related]
14. Is Li-Fraumeni syndrome really much more common?
Thomas DM
Hum Mutat; 2017 Dec; 38(12):1619. PubMed ID: 29091331
[No Abstract] [Full Text] [Related]
15. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and imaging surveillance in Li-Fraumeni syndrome.
Raskind WH; Hisama FM; Bennett RL
Lancet Oncol; 2016 Nov; 17(11):e472. PubMed ID: 27819239
[No Abstract] [Full Text] [Related]
17. Genetic modifiers of p53: opportunities for breast cancer therapies.
Majhi PD; Sharma A; Jerry DJ
Oncotarget; 2023 Mar; 14():236-241. PubMed ID: 36961913
[No Abstract] [Full Text] [Related]
18. Cancer surveillance for individuals with Li-Fraumeni syndrome.
Kratz CP; Villani A; Nichols KE; Schiffman J; Malkin D
Eur J Hum Genet; 2020 Nov; 28(11):1481-1482. PubMed ID: 32814850
[No Abstract] [Full Text] [Related]
19. Biochemical and imaging surveillance in Li-Fraumeni syndrome - Authors' reply.
Villani A; Malkin D
Lancet Oncol; 2016 Nov; 17(11):e473. PubMed ID: 27819240
[No Abstract] [Full Text] [Related]
20. Nodular Lymphocyte-predominant Hodgkin Lymphoma in a 15-Year-Old Boy With Li-Fraumeni Syndrome Having a Germline TP53 D49H Mutation.
Yamazaki F; Shima H; Osumi T; Narumi S; Kuroda T; Shimada H
J Pediatr Hematol Oncol; 2018 Apr; 40(3):e195-e197. PubMed ID: 28902083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
